The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Abstract
PI3K/AKT/mTOR pathway is one of the most important signaling pathways involved in normal cellular processes. Its aberrant activation modulates autophagy, epithelial-mesenchymal transition, apoptosis, chemoresistance, and metastasis in many human cancers. Emerging evidence demonstrates that some infections as well as epigenetic regulatory mechanisms can control PI3K/AKT/mTOR signaling pathway. In this review, we focused on the role of this pathway in gastric cancer development, prognosis, and metastasis, with an emphasis on epigenetic alterations including DNA methylation, histone modifications, and post-transcriptional modulations through non-coding RNAs fluctuations as well as H. pylori and Epstein-Barr virus infections. Finally, we reviewed different molecular targets and therapeutic agents in clinical trials as a potential strategy for gastric cancer treatment through the PI3K/AKT/mTOR pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Ueki, K., Fruman, D. A., Yballe, C. M., Fasshauer, M., Klein, J., Asano, T., Cantley, L. C., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305602200 · Cited by 208
RetractedHuang, Y., Zhang, J., Hou, L., Wang, G., Liu, H., Zhang, R., Chen, X., & Zhu, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0666-2 · Cited by 205
RetractedYang, P., Guo, J., Liu, Y., & Wu, X. (2014) · Bioscience Reports · doi:10.1042/bsr20140020 · Cited by 105
RetractedLi, C., Song, L., Zhang, Z., Bai, X., Cui, M., & Ma, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11888 · Cited by 57
RetractedRETRACTED: MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis
Lu, Z., Luo, T., Pang, T., Du, Z., Yin, X., Cui, H., Fang, G., & Xue, X. (2019) · Open Biology · doi:10.1098/rsob.190095 · Cited by 47
RetractedWei, T., Li, Y., Zhu, M., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s216862 · Cited by 45
RetractedGuo, J., Yan, L., Duan, H., & Lu, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0879-x · Cited by 30
RetractedMa, F.-Z., An, K., & Li, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s240965 · Cited by 24
RetractedLin, S., Wang, H., Yang, W., Wang, A., & Geng, C. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s220302 · Cited by 18
RetractedQin, L., Jia, Z., Xie, D., & Liu, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27344 · Cited by 17
RetractedZhu, L., Liu, X., Li, D., Sun, S., Wang, Y., & Sun, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.090 · Cited by 16
RetractedThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,678
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
The Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Mammalian autophagy: core molecular machinery and signaling regulation
Yang, Z., & Klionsky, D. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.014 · Cited by 1,956
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1692 · Cited by 1,654
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
Targeting PI3K/Akt/mTOR Signaling in Cancer
Porta, C., Paglino, C., & Mosca, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00064 · Cited by 1,485
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Autophagy-deficient mice develop multiple liver tumors
Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, O., Tanaka, K., & Mizushima, N. (2011) · Genes & Development · doi:10.1101/gad.2016211 · Cited by 1,342
The autophagosome: origins unknown, biogenesis complex
Lamb, C. A., Yoshimori, T., & Tooze, S. A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3696 · Cited by 1,314
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,241
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
The Double-Edged Sword of Autophagy Modulation in Cancer
White, E., & DiPaola, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5023 · Cited by 1,138
The role of the Atg1/ULK1 complex in autophagy regulation
Mizushima, N. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.004 · Cited by 1,062
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
Targeting PI3K/mTOR Signaling in Cancer
Arcaro, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00084 · Cited by 1,024
PI3K signalling: the path to discovery and understanding
Vanhaesebroeck, B., Stephens, L., & Hawkins, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3290 · Cited by 987
Phosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Recent insights into the function of autophagy in cancer
Amaravadi, R., Kimmelman, A. C., & White, E. (2016) · Genes & Development · doi:10.1101/gad.287524.116 · Cited by 813
The Atg8 and Atg12 ubiquitin‐like conjugation systems in macroautophagy
Geng, J., & Klionsky, D. J. (2008) · EMBO reports · doi:10.1038/embor.2008.163 · Cited by 780
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Xu, W., Yang, Z., & Lu, N. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1016686 · Cited by 608
The dynamic nature of autophagy in cancer
Kimmelman, A. C. (2011) · Genes & Development · doi:10.1101/gad.17558811 · Cited by 589
PI3K isoforms in cell signalling and vesicle trafficking
Bilanges, B., Posor, Y., & Vanhaesebroeck, B. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0129-z · Cited by 525
Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes
Simonsen, A., & Tooze, S. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200907014 · Cited by 497
Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., Dargemont, C., de Herreros, A. G., Bellacosa, A., & Larue, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210546 · Cited by 476
Control of autophagy by oncogenes and tumor suppressor genes
Maiuri, M. C., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J. M., Carnuccio, R., & Kroemer, G. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.131 · Cited by 435
Niwa, T., Tsukamoto, T., Toyoda, T., Mori, A., Tanaka, H., Maekita, T., Ichinose, M., Tatematsu, M., & Ushijima, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2755 · Cited by 417
Tsukamoto, Y., Nakada, C., Noguchi, T., Tanigawa, M., Nguyen, L. T., Uchida, T., Hijiya, N., Matsuura, K., Fujioka, T., Seto, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2777 · Cited by 392
Amino Acids Activate mTOR Complex 1 via Ca2+/CaM Signaling to hVps34
Gulati, P., Gaspers, L. D., Dann, S. G., Joaquin, M., Nobukuni, T., Natt, F., Kozma, S. C., Thomas, A. P., & Thomas, G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.002 · Cited by 370
Role and regulation of autophagy in cancer
Chen, N., & Karantza-Wadsworth, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.013 · Cited by 357
p21-Activated Kinase 1 Phosphorylates the Death Agonist Bad and Protects Cells from Apoptosis
Schürmann, A., Mooney, A. F., Sanders, L. C., Sells, M. A., Wang, H. G., Reed, J. C., & Bokoch, G. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.453-461.2000 · Cited by 356
Zhang, E.-B., Kong, R., Yin, D.-D., You, L.-H., Sun, M., Han, L., Xu, T.-P., Xia, R., Yang, J.-S., De, W., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1902 · Cited by 351
MiRNA as potential biomarkers and therapeutic targets for gastric cancer
Shin, V. Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10432 · Cited by 343
PI3k/AKT signaling pathway: Erythropoiesis and beyond
Jafari, M., Ghadami, E., Dadkhah, T., & Akhavan‐Niaki, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27262 · Cited by 324
Self-citationAkt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Xu, N., Lao, Y., Zhang, Y., & Gillespie, D. A. (2012) · Journal of Oncology · doi:10.1155/2012/951724 · Cited by 302
The Emerging Roles of mTORC1 in Macromanaging Autophagy
Dossou, A. S., & Basu, A. (2019) · Cancers · doi:10.3390/cancers11101422 · Cited by 288
Organization of the Pre-autophagosomal Structure Responsible for Autophagosome Formation
Kawamata, T., Kamada, Y., Kabeya, Y., Sekito, T., & Ohsumi, Y. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1048 · Cited by 286
Pan, H., Li, T., Jiang, Y., Pan, C., Ding, Y., Huang, Z., Yu, H., & Kong, D. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26201 · Cited by 277
Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer
Chin, Y. R., & Toker, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.015 · Cited by 255
Promoter Methylation and Silencing of PTEN in Gastric Carcinoma
Kang, Y.-H., Lee, H. S., & Kim, W. H. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780422 · Cited by 231
Jones, R. H., Casbard, A., Carucci, M., Cox, C., Butler, R., Alchami, F., Madden, T.-A., Bale, C., Bezecny, P., Joffe, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30817-4 · Cited by 229
The Pancreatitis-induced Vacuole Membrane Protein 1 Triggers Autophagy in Mammalian Cells
Ropolo, A., Grasso, D., Pardo, R., Sacchetti, M. L., Archange, C., Re, A. L., Seux, M., Nowak, J., Gonzalez, C. D., Iovanna, J. L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706956200 · Cited by 223
Chen, J.-F., Wu, P., Xia, R., Yang, J., Huo, X.-Y., Gu, D.-Y., Tang, C.-J., De, W., & Yang, F. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0756-y · Cited by 220
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
Yang, S.-M., Huang, C., Li, X.-F., Yu, M.-Z., He, Y., & Li, J. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.014 · Cited by 211
Twist: a molecular target in cancer therapeutics
Khan, M. A., Chen, H.-C., Zhang, D., & Fu, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1002-x · Cited by 209
Yu, H., Ai, Y., Yu, L., Zhou, X., Liu, J., Li, J., Xu, X., Liu, S., Chen, J., Liu, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23049 · Cited by 203
Zhang, X.-W., Bu, P., Liu, L., Zhang, X.-Z., & Li, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.121 · Cited by 202
Emerging role of PI3K/AKT in tumor-related epigenetic regulation
Yang, Q., Jiang, W., & Hou, P. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.04.001 · Cited by 202
Zhang, K., Shi, H., Xi, H., Wu, X., Cui, J., Gao, Y., Liang, W., Hu, C., Liu, Y., Li, J., et al. (2017) · Theranostics · doi:10.7150/thno.16044 · Cited by 193
Wang, X., Zhang, H., Bai, M., Ning, T., Ge, S., Deng, T., Liu, R., Zhang, L., Ying, G., & Ba, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.001 · Cited by 192
Regulation of Autophagy by Kinases
Sridharan, S., Jain, K., & Basu, A. (2011) · Cancers · doi:10.3390/cancers3022630 · Cited by 181
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh, S. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12261 · Cited by 179
Yip, P. Y. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.01.04 · Cited by 174
Rohde, G., Wenzel, D., & Haucke, V. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200203103 · Cited by 171
MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
Wang, F., Li, T., Zhang, B., Li, H., Wu, Q., Yang, L., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.010 · Cited by 170
Yan, J., Dang, Y., Liu, S., Zhang, Y., & Zhang, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-5448-5 · Cited by 168
Cheng, C., Qin, Y., Zhi, Q., Wang, J., & Qin, C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.10.154 · Cited by 166
Terakawa, N., Kanamori, Y., & Yoshida, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100203 · Cited by 161
Hong, K., Kim, J. H., Hong, J., Yoon, H., Lee, J., Hong, S., & Hong, S. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-28 · Cited by 159
Regulation and cellular functions of class II phosphoinositide 3-kinases
Falasca, M., & Maffucci, T. (2012) · Biochemical Journal · doi:10.1042/bj20120008 · Cited by 158
Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Sangai, T., Akcakanat, A., Chen, H., Tarco, E., Wu, Y., Do, K.-A., Miller, T. W., Arteaga, C. L., Mills, G. B., Gonzalez-Angulo, A. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1141 · Cited by 158
Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway
Nakayama, M., Hisatsune, J., Yamasaki, E., Isomoto, H., Kurazono, H., Hatakeyama, M., Azuma, T., Yamaoka, Y., Yahiro, K., Moss, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806981200 · Cited by 154
Miao, Y., Zheng, W., Li, N., Su, Z., Zhao, L., Zhou, H., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep41942 · Cited by 150
Helicobacter pylori -induced inflammation and epigenetic changes during gastric carcinogenesis
Valenzuela, M., Canales, J., Corvalán, A. H., & Quest, A. F. G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i45.12742 · Cited by 147
Wang, Z., Cai, Q., Hu, L., He, C., Li, J., Quan, Z.-W., Liu, B., Li, C., & Zhu, Z. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.143 · Cited by 144
Selvendiran, K., Tong, L., Vishwanath, S., Bratasz, A., Trigg, N. J., Kutala, V. K., Hideg, K., & Kuppusamy, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703796200 · Cited by 137
Lee, H. J., Saralamma, V. V. G., Kim, S. M., Ha, S. E., Raha, S., Lee, W. S., Kim, E. H., Lee, S. J., Heo, J., & Kim, G. S. (2018) · Nutrients · doi:10.3390/nu10081043 · Cited by 136
The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside
Liu, X., & Cohen, J. I. (2015) · Virology · doi:10.1016/j.virol.2015.02.040 · Cited by 124
Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway
Zhou, J., Zhi, X., Wang, L., Wang, W., Li, Z., Tang, J., Wang, J., Zhang, Q., & Xu, Z. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0250-6 · Cited by 124
Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2A
Moody, C. A., Scott, R. S., Amirghahari, N., Nathan, C. O., Young, L. S., Dawson, C., & Sixbey, J. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5499-5506.2005 · Cited by 123
hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling
Nobukuni, T., Kozma, S. C., & Thomas, G. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.019 · Cited by 123
Nagy, T. A., Frey, M. R., Yan, F., Israel, D. A., Polk, D. B., & Peek, R. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/596660 · Cited by 120
Gao (2010) · International Journal of Oncology · doi:10.3892/ijo_00000715 · Cited by 118
Li, Y., Ye, Y., Feng, B., & Qi, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26107 · Cited by 118
Li, C., Wang, Y., Wang, C., Yi, X., Ming-ya, L., & He, X. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.02.008 · Cited by 115
Lin, Y., Wang, H., Hsu, Y., Cho, C.-L., Yang, M., & Chien, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071343 · Cited by 113
Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3
Maeda, M., Takeshima, H., Iida, N., Hattori, N., Yamashita, S., Moro, H., Yasukawa, Y., Nishiyama, K., Hashimoto, T., Sekine, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317645 · Cited by 111
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer
Liu, G., Jiang, C., Li, D., Wang, R., & Wang, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2273-6 · Cited by 110
Epigenetic Mechanisms in Gastric Cancer
Gigek, C. O., Chen, E., Calcagno, D. Q., Wisnieski, F., Burbano, R. M. R., & Smith, M. D. A. C. (2012) · Epigenomics · doi:10.2217/epi.12.22 · Cited by 109
Liu, X., Li, Z., Song, Y., Wang, R., Han, L., Wang, Q., Jiang, K., Kang, C., & Zhang, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.8888 · Cited by 104
Schoenwaelder, S. M., Ono, A., Sturgeon, S. A., Chan, S. M., Mangin, P., Maxwell, M. J., Turnbull, S., Mulchandani, M., Anderson, K. E., Kauffenstein, G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704358200 · Cited by 99
Cárdenas-Mondragón, M. G., Carreón-Talavera, R., Camorlinga‐Ponce, M., Gómez-Delgado, A., Torres, J., & Fuentes‐Pananá, E. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062850 · Cited by 98
Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications
Chen, J. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i6.154 · Cited by 95
Wu, Q., Ma, J., Wei, J., Meng, W., Wang, Y., & Shi, M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12728 · Cited by 93
de Souza, C. R. T., Almeida, M. C. A., Khayat, A. S., da Silva, E. L., Soares, P. C., Chaves, L. C., & Burbano, R. M. R. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4928 · Cited by 92
Hur, K., Niwa, T., Toyoda, T., Tsukamoto, T., Tatematsu, M., Yang, H., & Ushijima, T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq219 · Cited by 90
Liu, H., Ma, R., Lv, B., Zhang, H., Shi, D., Guo, X., Zhang, G., & Gao, P. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0836-4 · Cited by 90
Turner, N. C., Alarcon-Rozas, A. E., Armstrong, A. C., Philco, M., Chuken, Y. A. L., Sablin, M., Tamura, K., Villanueva, A. G., Fidalgo, J. A. P., Cheung, S. Y. A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz086 · Cited by 89
Dai, Q., Zhang, T., Pan, J., & Li, C. (2020) · Journal of Cancer · doi:10.7150/jca.43446 · Cited by 87
Madeddu, P. R., Kränkel, N., Barcelos, L. S., Siragusa, M., Campagnolo, P., Oikawa, A., Caporali, A., Herman, A., Azzolino, O., Barberis, L., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.145573 · Cited by 85
Epigenetic alterations in gastric cancer (Review)
Fu, D.-G. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3816 · Cited by 85
Dai, Q., Zhang, T., & Li, C. (2020) · Cancer Management and Research · doi:10.2147/cmar.s243796 · Cited by 84
Song, Y., Li, Z., Liu, X., Wang, R., Li, L.-W., & Zhang, Q. (2017) · Tumor Biology · doi:10.1177/1010428317712617 · Cited by 79
Role of autophagy in head and neck cancer and therapeutic resistance
Sannigrahi, M. K., Singh, V., Sharma, R., Panda, N., & Khullar, M. (2014) · Oral Diseases · doi:10.1111/odi.12254 · Cited by 78
miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells
Fang, Y., Shen, H., Li, H., Cao, Y., Qin, R., Long, L., Zhu, X., Xie, C., & Xu, W. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt106 · Cited by 77
Wang, Z., Tang, F., Qi, G., Yuan, S., Zhang, G., Tang, B., & He, S. (2015) · Europe PMC (PubMed Central) · Cited by 73
Kim, S. T., Kim, S., Klempner, S. J., Yoon, J. Y., Kim, N., Ahn, S., Bang, H., Kim, K., Park, W., Park, S. H., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw669 · Cited by 72
Iacovelli, R., Pietrantonio, F., Farcomeni, A., Maggi, C., Palazzo, A., Ricchini, F., de Braud, F., & Bartolomeo, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108940 · Cited by 70
A PI3K activity‐independent function of p85 regulatory subunit in control of mammalian cytokinesis
García, Z., Silió, V., Marqués, M., Cortés, I., Kumar, A., Hernandez, C., Checa, A. I., Serrano, A., & Carrera, A. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601324 · Cited by 70
Amini‐Farsani, Z., Sangtarash, M. H., Shamsara, M., & Teimori, H. (2017) · Cytotechnology · doi:10.1007/s10616-017-0134-z · Cited by 68
Li, X., Yan, X., Wang, F., Yang, Q., Luo, X., Kong, J., & Ju, S.-Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14200 · Cited by 66
Wang, Z., Wang, Q., Xu, G., Meng, N., Huang, X., Jiang, Z., Chen, C., Zhang, Y., Chen, J., Li, A., et al. (2019) · RNA Biology · doi:10.1080/15476286.2019.1709296 · Cited by 66
Gastric cancer and related epigenetic alterations
Patel, T., Roy, S., & Ravi, R. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.714 · Cited by 65
Li, Y., Gu, J., & Lu, H. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4831-4 · Cited by 64
Zhang, B.-G., Hu, L., Zang, M., Wang, H., Zhao, W., Li, J., Su, L., Shao, Z., Zhao, X., Zhu, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7125 · Cited by 62
Guo, J., Li, S., & Guo, G.-X. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4584-0 · Cited by 60
Zeng, L., Liao, Q., Zou, Z., Wen, Y., Wang, J., Liu, C., He, Q., Weng, N., Zeng, J., Tang, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495499 · Cited by 57
Differential roles of YTHDF1 and YTHDF3 in embryonic stem cell-derived cardiomyocyte differentiation
Wang, S., Zhang, J., Xiang, W., Lin, X., Liu, X., & Zhou, J. L. (2020) · RNA Biology · doi:10.1080/15476286.2020.1850628 · Cited by 57
Upregulation of Twist in Gastric Carcinoma Associated with Tumor Invasion and Poor Prognosis
Ru, G., Wang, H., Xu, W.-J., & Zhao, Z. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9332-0 · Cited by 55
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
Lee, D., Yu, E. J., Ham, I., Hur, H., & Kim, Y.-S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s139664 · Cited by 54
Divide and ProsPer: The emerging role of PtdIns3P in cytokinesis
Nezis, I. P., Sagona, A. P., Schink, K. O., & Stenmark, H. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.010 · Cited by 52
D’Andrea, I., Fardella, V., Fardella, S., Pallante, F., Ghigo, A., Iacobucci, R., Maffei, A., Hirsch, E., Lembo, G., & Carnevale, D. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404697 · Cited by 52
An orthotopic mouse model of gastric cancer invasion and metastasis
Busuttil, R. A., Liu, D. S., Costanzo, N. D., Schröder, J., Mitchell, C., & Boussioutas, A. (2018) · Scientific Reports · doi:10.1038/s41598-017-19025-y · Cited by 52
Epstein–Barr virus‐induced epigenetic alterations following transient infection
Queen, K. J., Shi, M., Zhang, F., Cvek, U., & Scott, R. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27893 · Cited by 49
MK-2206, an AKT Inhibitor, Promotes Caspase-Independent Cell Death and Inhibits Leiomyoma Growth
Sefton, E. C., Qiang, W., Serna, V. A., Kurita, T., Wei, J., Chakravarti, D., & Kim, J. J. (2013) · Endocrinology · doi:10.1210/en.2013-1389 · Cited by 47
Hu, J., Qian, Y., Peng, L., Ma, L., Qiu, T., Liu, Y., Xiao, L., & Chen, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492883 · Cited by 47
Dong, S., Zhang, X., & Liu, D. (2019) · Biology Open · doi:10.1242/bio.041343 · Cited by 47
Bang, Y.-J., Kang, Y., Ng, M. C. H., Chung, H. C., Wainberg, Z. A., Gendreau, S. B., Chan, W., Xu, N., Maslyar, D. J., Meng, R. D., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.017 · Cited by 46
Chen, X., Dai, X., Zou, P., Chen, W., Rajamanickam, V., Feng, C., Zhuge, W., Qiu, C., Ye, Q., Zhang, X., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13765 · Cited by 45
Yang, L., Yang, G., Ding, Y., Huang, Y., Liu, S., Zhou, L., Wei, W., Wang, J., & Hu, G. (2018) · Oncology Reports · doi:10.3892/or.2018.6445 · Cited by 45
Kim, K., Kim, J., Sung, J. H., Suh, K. J., Lee, J. Y., Kim, S. H., Lee, J., Kim, J. W., Kim, Y. J., Kim, J. H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68998-w · Cited by 45
Matuszcak, C., Haier, J., Hummel, R., & Lindner, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13658 · Cited by 43
Cai, J., Qian, K., Zuo, X., Yue, W., Bian, Y., Yang, J. D., Wei, J., Zhao, W., Qian, H., & Li, R. (2019) · Journal of Biomaterials Applications · doi:10.1177/0885328219837683 · Cited by 43
Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells
Tao, K., Yin, Y., Shen, Q., Chen, Y., Li, R., Chang, W., Bai, J., Liu, W., Shi, L., & Zhang, P. (2016) · Biomedical Reports · doi:10.3892/br.2016.594 · Cited by 42
Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance
Liu, W., Chang, J., Liu, M., Yuan, J., Zhang, J., Qin, J., Xia, X., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17415 · Cited by 42
Daniel, P. M., Filiz, G., Brown, D. V., Christie, M., Waring, P., Zhang, Y., Haynes, J. M., Pouton, C. W., Flanagan, D. J., Vincan, E., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy068 · Cited by 42
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1
Lloyd, K., Moore, A. R., Parsons, B. N., O'Hara, A., Boyce, M. J., Dockray, G. J., Varró, A., & Pritchard, D. M. (2016) · Oncotarget · doi:10.18632/oncotarget.9990 · Cited by 41
Zhao, E., Tang, C., Jiang, X., Weng, X., Zhong, X., Zhang, D., Hou, J., Wang, F., Huang, M., & Cui, H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.05.011 · Cited by 41
Kosari‐Monfared, M., Nikbakhsh, N., Fattahi, S., Ghadami, E., Ranaei, M., Taheri, H., Amjadi‐Moheb, F., Godazandeh, G., Shafaei, S., Langroudi, M. P., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27106 · Cited by 40
Self-citationLY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2
Lu, J. L., Chen, M., Gao, S., Yuan, J., Zhu, Z., & Zou, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7843 · Cited by 39
Ghadami, E., Nikbakhsh, N., Fattahi, S., Kosari‐Monfared, M., Ranaee, M., Taheri, H., Amjadi‐Moheb, F., Godazandeh, G., Shafaei, S., Nosrati, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27220 · Cited by 39
Self-citationResistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
Beyens, M., Vandamme, T., Peeters, M., Camp, G. V., & de Beeck, K. O. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0420 · Cited by 39
Pei, L., He, X., Li, S., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4446 · Cited by 38
Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway
Xu, W., Huang, Y., Yang, Z., Hu, Y., Shu, X., Xie, C., He, C., Zhu, Y., & Lü, N. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s164749 · Cited by 38
Wu, F., Li, R., Yang, M., Yue, G., Wang, H., Liu, Q., Cui, F., Wu, P., Ding, H., Yu, L., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.006 · Cited by 37
Sha, M., Ye, J., Luan, Z., Guo, T., Wang, B., & Huang, J. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0256-3 · Cited by 36
DNA Methyltransferases and Gastric Cancer: Insight Into Targeted Therapy
Fattahi, S., Golpour, M., Amjadi‐Moheb, F., Pasandi, M. S., Khodadadi, P., Langroudi, M. P., Ashrafi, G. H., & Akhavan‐Niaki, H. (2018) · Epigenomics · doi:10.2217/epi-2018-0096 · Cited by 35
Self-citationExpression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer
Honma, R., Goto, K., Sakamoto, N., Sekino, Y., Sentani, K., Oue, N., & Yasui, W. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0714-9 · Cited by 34
Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer
Solomon, B., & Pearson, R. B. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a74dba · Cited by 33
Yu, W., Jiang, H., Zhang, C., & Yang, P. (2017) · Oncotarget · doi:10.18632/oncotarget.16849 · Cited by 33
Yu, Z., Wang, Z., Lee, K., Yuan, P., & Ding, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7677 · Cited by 33
miR-21 modulates prostaglandin signaling and promotes gastric tumorigenesis by targeting 15-PGDH
Li, L., Wang, X., Li, W., Yang, L., Liu, R., Zeng, R., Wu, Y., & Shou, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.137 · Cited by 30
Li, C., Liang, G., Yang, S., Sui, J., Wu, W., Xu, S., Ye, Y., Shen, B., Zhang, X., & Zhang, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2165 · Cited by 29
Moro, H., Hattori, N., Nakamura, Y., Kimura, K., Imai, T., Maeda, M., Yashiro, M., & Ushijima, T. (2019) · Gastric Cancer · doi:10.1007/s10120-019-01010-1 · Cited by 28
Eltantawy, A., Vallejos, X., Sebea, E., & Evans, K. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019833992 · Cited by 27
TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma
Kwon, M. J., Kwon, J. H., Nam, E. S., Shin, H. S., Lee, D. J., Kim, J. H., Rho, Y. S., Sung, C. O., Lee, W. J., & Cho, S. J. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.03.004 · Cited by 26
LY294002 induces p53-dependent apoptosis of SGC7901 gastric cancer cells
Chun-gen, X. I. N. G., Zhu, B.-S., Hui-hui, L. I. U., Lin, F., Yao, H., Liang, Z., & Qin, Z. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00770.x · Cited by 25
Class II phosphoinositide 3-kinase C2alpha: what we learned so far.
Mazza, S., & Maffucci, T. (2011) · Europe PMC (PubMed Central) · Cited by 23
Natural agents mediated autophagic signal networks in cancer
Sohn, E. J., & Park, H. T. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0486-7 · Cited by 23
Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation
Zhang, W., Tan, Y.-S., & Ma, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6858 · Cited by 20
Nasrollahzadeh-Khakiani, M., Emadi‐Baygi, M., & Nikpour, P. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9448 · Cited by 20
Livi, G. P. (2019) · Gene · doi:10.1016/j.gene.2018.12.046 · Cited by 14
Li, D., Xu, C., Cui, R., Tang, J., Sun, H., Yang, Z., Bu, J., LIN, P., Huang, N., Du, Y., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4424 · Cited by 13
Scaffolding Function of PI3Kgamma Emerges from Enzyme's Shadow
Mohan, M. L., & Prasad, S. V. N. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.01.023 · Cited by 9
Ueki, K., Fruman, D. A., Yballe, C. M., Faßhauer, M., Klein, J. C., Asano, T., Cantley, L. C., & Kahn, C. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.a117.305602 · Cited by 7
Common shared genetic variation behind decreased risk of breast cancer in celiac disease
Ugalde‐Morales, E., Li, J., Humphreys, K., Ludvigsson, J. F., Yang, H., Hall, P. N., & Czene, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-06287-9 · Cited by 6
Temsirolimus: A Review of its Use in the Treatment of Advanced Renal Cell Carcinoma
Chan, F., Samlowski, E. E., & Samlowski, W. E. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2349 · Cited by 5
Bradley, D. T. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400872101 · Cited by 4
Cited by
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Yu, L., Wei, J., & Liu, P. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 763
CCL5/CCR5 axis in human diseases and related treatments
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 378
Metadata
- Authors
- Fattahi, S., Amjadi-Moheb, F., Tabaripour, R., Ashrafi, G. H., & Akhavan-Niaki, H.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 262
- Pages
- 118513
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W3090967605
- Cited by
- 400
- References
- 179
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.